Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Cytokeratin 13 Antikörper

Dieses Maus Monoklonal-Antikörper erkennt spezifisch Cytokeratin 13 in IF, FACS und IHC (f). Er zeigt eine Reaktivität gegenüber Human.
Produktnummer ABIN6937655

Kurzübersicht für Cytokeratin 13 Antikörper (ABIN6937655)

Target

Alle Cytokeratin 13 (KRT13) Antikörper anzeigen
Cytokeratin 13 (KRT13) (Keratin 13 (KRT13))

Reaktivität

  • 91
  • 36
  • 32
  • 11
  • 6
  • 5
  • 4
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Human

Wirt

  • 64
  • 32
  • 1
  • 1
Maus

Klonalität

  • 57
  • 41
Monoklonal

Konjugat

  • 55
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser Cytokeratin 13 Antikörper ist unkonjugiert

Applikation

  • 62
  • 45
  • 16
  • 16
  • 16
  • 16
  • 13
  • 12
  • 11
  • 11
  • 7
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Immunofluorescence (IF), Flow Cytometry (FACS), Immunohistochemistry (Formalin-fixed Sections) (IHC (f))

Klon

KRT13-2213
  • Spezifität

    Cytokeratin 13 (KRT13) is the major acidic keratin, which together with KRT4, its basic partner, is expressed in the suprabasal layers of non-cornified stratified epithelia including tongue mucosa, esophagus, anal canal epithelium, tracheal epithelium, uterine cervix, and urothelium. Defects in the KRT13 gene are a cause of white sponge nevus of cannon (WSN), a rare autosomal dominant disorder, which predominantly affects non-cornified stratified squamous epithelia and is characterized by the presence of soft, white and spongy plaques in the oral mucosa. KRT13 has been used as a marker for non-keratinized squamous epithelium. It is also expressed in various squamous metaplasia, but it is down regulated in squamous dysplasia and squamous carcinoma.

    Kreuzreaktivität (Details)

    Human.

    Aufreinigung

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogen

    Recombinant full-length human KRT13 protein

    Isotyp

    IgG
  • Applikationshinweise

    Known_Application: Immunofluorescence (1-2 μg/mL), Flow Cytometry (1-2 μg per million cells), Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 min at RT)(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95°C followed by cooling at RT for 20 minutes), Optimal dilution for a specific application should be determined.

    Positive_Control: HeLa or A431 cells. Skin or squamous cell carcinoma.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Konservierungsmittel

    Azide free

    Lagerung

    -20 °C,-80 °C

    Informationen zur Lagerung

    Antibody without azide store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Haltbarkeit

    24 months
  • Target

    Cytokeratin 13 (KRT13) (Keratin 13 (KRT13))

    Andere Bezeichnung

    KRT13

    Hintergrund

    CK13, Cytokeratin-13, Keratin Type I Cytoskeletal 13, Keratin-13, KRT13, Type I Cytoskeletal 13, WSN2,Cytokeratin 13 (Non-Keratinized Squamous Epithelial Marker)
    Cellular localisation: Cytoplasmic

    Molekulargewicht

    52kDa

    Gen-ID

    3860, 654550

    UniProt

    P13646
Sie sind hier:
Chat with us!